National Cancer Institute   U.S. National Institutes of Healthwww.cancer.gov
 
Home   |   Data & Statistics   |   Collaborations   |   Work with Us   |   Publications   |   About   |   Links

Performance Measures for 273,601 Diagnostic Mammography Examinations1 from 1996 to 2007 by Age & Time (Months) Since Previous Mammography

PPV22 Abnormal Interpretation3
Age 40-44 22.5% 8.8%
<=15 months 18.8% 7.8%
16-20 months 18.7% 7.0%
21-27 months 24.6% 8.1%
28+ months 23.7% 9.3%
No previous mammography 30.1% 13.8%
Age 45-49 29.3% 8.7%
<=15 months 24.4% 7.8%
16-20 months 26.9% 7.4%
21-27 months 30.2% 7.8%
28+ months 36.2% 10.6%
No previous mammography 41.7% 18.4%
Age 50-54 33.7% 8.4%
<=15 months 28.5% 7.8%
16-20 months 36.1% 7.2%
21-27 months 36.7% 7.7%
28+ months 47.1% 10.6%
No previous mammography 47.4% 20.5%
Age 55-59 41.1% 8.1%
<=15 months 34.8% 7.2%
16-20 months 42.1% 7.1%
21-27 months 48.4% 8.2%
28+ months 56.4% 11.8%
No previous mammography 60.5% 26.8%
Age 60-64 42.6% 8.0%
<=15 months 36.5% 7.0%
16-20 months 44.4% 6.9%
21-27 months 45.7% 7.8%
28+ months 59.6% 12.2%
No previous mammography 62.9% 26.5%
Age 65-69 46.8% 8.5%
<=15 months 40.3% 7.2%
16-20 months 38.4% 7.4%
21-27 months 53.3% 10.1%
28+ months 65.3% 14.0%
No previous mammography 67.0% 29.4%
Age 70-74 51.4% 9.2%
<=15 months 41.5% 7.5%
16-20 months 54.3% 7.3%
21-27 months 58.4% 9.8%
28+ months 70.1% 16.9%
No previous mammography 75.1% 34.0%
Age 75-89 56.3% 11.4%
<=15 months 45.2% 7.8%
16-20 months 56.0% 8.6%
21-27 months 59.5% 12.2%
28+ months 69.5% 22.0%
No previous mammography 68.1% 41.6%

1 Diagnostic mammography examination: Mammography examinations indicated by the radiologist to be for evaluation of a breast problem.

2 PPV2 (Positive Predictive Value 2) = The percentage of examinations with a positive interpretation& that result in a tissue diagnosis of cancer§.

3 Abnormal interpretation = The percentage of examinations with a positive interpretation&.

§Cancers = Examinations with a tissue diagnosis of ductal carcinoma in situ or invasive cancer within 30 days prior to or 1 year following the examination. Non-cancers = Examinations without a tissue diagnosis of ductal carcinoma in situ or invasive cancer within 30 days prior to or 1 year following the examination.

& Positive interpretation = BI-RADS category 0 or 3 with a recommendation for biopsy, 4, or 5.

Negative interpretation = BI-RADS category 1, 2, 0 with no recommendation for biopsy nor additional imaging/work-up, or 3 with no recommendation for biopsy.

[Return to Diagnostic Performance]


National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov: The US government's official web portal Maintained by the Applied Research Program,
Division of Cancer Control and Population Sciences